In their work, Ren et al. demonstrated that naïve B-cells activated via CD40 or TLR and loaded with tumor-derived autophagosomes selectively capturing TSAs could lead to tumor regression in E.G7 murine thymoma models [80]. Here, CD40 is linked to neoplasm.